Inhibition of DNA Topoisomerase Type II alpha (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study - Université Claude Bernard Lyon 1 Access content directly
Journal Articles BioMed Research International Year : 2016

Inhibition of DNA Topoisomerase Type II alpha (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study

Abstract

In this study, mitoxantrone and its halogenated derivatives have been designed by density functional theory (DFT) to explore their structural and thermodynamical properties. The performance of these drugs was also evaluated to inhibit DNA topoisomerase type II (TOP2A) by molecular docking calculation. Noncovalent interactions play significant role in improving the performance of halogenated drugs. The combined quantum and molecular mechanics calculations revealed that CF 3 containing drug shows better preference in inhibiting the TOP2A compared to other modified drugs.
Fichier principal
Vignette du fichier
6817502.pdf (1.9 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-02304947 , version 1 (10-02-2021)

Identifiers

Cite

Md. Abu Saleh, Md. Solayman, Mohammad Mazharol Hoque, Mohammad A. K. Khan, Mohammed G. Sarwar, et al.. Inhibition of DNA Topoisomerase Type II alpha (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study. BioMed Research International , 2016, 2016, pp.6817502. ⟨10.1155/2016/6817502⟩. ⟨hal-02304947⟩
16 View
50 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More